Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 3 | 2022 | 1724 | 0.280 |
Why?
|
| Marketing | 1 | 2003 | 24 | 0.230 |
Why?
|
| Ethics, Medical | 1 | 2003 | 70 | 0.220 |
Why?
|
| Drug Industry | 1 | 2003 | 104 | 0.210 |
Why?
|
| Coronary Stenosis | 1 | 2022 | 39 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 2408 | 0.200 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 40 | 0.200 |
Why?
|
| Coronary Disease | 3 | 2012 | 349 | 0.160 |
Why?
|
| Animals, Domestic | 1 | 1998 | 11 | 0.160 |
Why?
|
| Chest Pain | 3 | 2022 | 82 | 0.150 |
Why?
|
| Social Class | 1 | 1998 | 213 | 0.140 |
Why?
|
| Mortality | 1 | 1998 | 293 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 990 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 611 | 0.130 |
Why?
|
| Physicians | 1 | 2003 | 774 | 0.130 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 253 | 0.130 |
Why?
|
| Hypertension | 2 | 2012 | 1063 | 0.120 |
Why?
|
| Health Status | 1 | 1998 | 733 | 0.110 |
Why?
|
| Coronary Angiography | 2 | 2022 | 313 | 0.110 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2012 | 9 | 0.100 |
Why?
|
| Chlorthalidone | 2 | 2012 | 5 | 0.090 |
Why?
|
| Contraindications | 1 | 2008 | 85 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 488 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 108 | 0.070 |
Why?
|
| Triage | 1 | 2009 | 192 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 219 | 0.070 |
Why?
|
| Amlodipine | 1 | 2005 | 8 | 0.070 |
Why?
|
| Lisinopril | 1 | 2005 | 14 | 0.060 |
Why?
|
| Contrast Media | 1 | 2008 | 366 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2008 | 554 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 656 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 906 | 0.060 |
Why?
|
| Southeastern United States | 2 | 2001 | 30 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 430 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2003 | 246 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2003 | 258 | 0.050 |
Why?
|
| Adolescent Psychiatry | 1 | 2001 | 12 | 0.050 |
Why?
|
| Hypoglycemia | 1 | 2005 | 387 | 0.050 |
Why?
|
| Adolescent Health Services | 1 | 2001 | 67 | 0.040 |
Why?
|
| Middle Aged | 7 | 2022 | 27080 | 0.040 |
Why?
|
| Humans | 11 | 2022 | 115890 | 0.040 |
Why?
|
| Health Surveys | 1 | 1998 | 449 | 0.040 |
Why?
|
| Mental Health Services | 1 | 2001 | 326 | 0.040 |
Why?
|
| Female | 9 | 2022 | 60076 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3086 | 0.030 |
Why?
|
| Calcium | 1 | 2022 | 1102 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2003 | 4670 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1358 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 1995 | 122 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2003 | 949 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1728 | 0.030 |
Why?
|
| Male | 8 | 2012 | 56123 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 8714 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2012 | 931 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2001 | 908 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2012 | 62 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 2012 | 67 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 2090 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 115 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 180 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 1088 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2009 | 256 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 310 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 1998 | 4449 | 0.020 |
Why?
|
| Aged | 4 | 2012 | 19296 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 53 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 170 | 0.020 |
Why?
|
| California | 1 | 2009 | 369 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 2008 | 72 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 451 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2008 | 162 | 0.020 |
Why?
|
| Physarum | 1 | 1986 | 4 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 1986 | 17 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2008 | 175 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 970 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 917 | 0.020 |
Why?
|
| Adolescent | 3 | 2001 | 17949 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1986 | 124 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 1986 | 87 | 0.020 |
Why?
|
| Child | 3 | 2001 | 18550 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2005 | 4446 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 3004 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 4961 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1986 | 594 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1665 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 2598 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2001 | 485 | 0.010 |
Why?
|
| Animals | 2 | 1998 | 32120 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6186 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 1842 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2001 | 397 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 6266 | 0.010 |
Why?
|
| Schools | 1 | 2001 | 401 | 0.010 |
Why?
|
| Adult | 3 | 2008 | 30814 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 1826 | 0.010 |
Why?
|
| Sex Factors | 1 | 2001 | 1743 | 0.010 |
Why?
|
| Aid to Families with Dependent Children | 1 | 1995 | 4 | 0.010 |
Why?
|
| National Health Insurance, United States | 1 | 1995 | 5 | 0.010 |
Why?
|
| Cost Control | 1 | 1995 | 40 | 0.010 |
Why?
|
| State Health Plans | 1 | 1995 | 32 | 0.010 |
Why?
|
| Incidence | 1 | 2001 | 2333 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2001 | 2437 | 0.010 |
Why?
|
| Managed Care Programs | 1 | 1995 | 135 | 0.010 |
Why?
|
| Mass Screening | 1 | 2001 | 1023 | 0.010 |
Why?
|
| Health Care Reform | 1 | 1995 | 92 | 0.010 |
Why?
|
| Age Factors | 1 | 2001 | 2915 | 0.010 |
Why?
|
| Forecasting | 1 | 1995 | 332 | 0.010 |
Why?
|
| Data Collection | 1 | 1995 | 636 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 9165 | 0.010 |
Why?
|
| Medicaid | 1 | 1995 | 411 | 0.010 |
Why?
|
| Medicare | 1 | 1995 | 666 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1986 | 19 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1986 | 116 | 0.000 |
Why?
|
| RNA, Fungal | 1 | 1986 | 66 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1986 | 180 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1986 | 335 | 0.000 |
Why?
|
| Epitopes | 1 | 1986 | 438 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1986 | 1262 | 0.000 |
Why?
|
| Liver | 1 | 1986 | 1693 | 0.000 |
Why?
|
| United States | 1 | 1995 | 12340 | 0.000 |
Why?
|
| Rats | 1 | 1986 | 5035 | 0.000 |
Why?
|